Vanguard Group Inc. Has $233.17 Million Stock Holdings in Acadia Healthcare Company, Inc. $ACHC

Vanguard Group Inc. boosted its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 7.8% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,417,045 shares of the company’s stock after purchasing an additional 681,278 shares during the period. Vanguard Group Inc. owned about 10.20% of Acadia Healthcare worth $233,166,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Abrams Bison Investments LLC lifted its holdings in shares of Acadia Healthcare by 96.7% in the 2nd quarter. Abrams Bison Investments LLC now owns 3,580,000 shares of the company’s stock worth $81,230,000 after acquiring an additional 1,760,000 shares during the last quarter. State Street Corp lifted its position in shares of Acadia Healthcare by 3.2% in the second quarter. State Street Corp now owns 3,095,775 shares of the company’s stock worth $70,243,000 after buying an additional 95,670 shares in the last quarter. Maverick Capital Ltd. grew its holdings in Acadia Healthcare by 13.6% during the 2nd quarter. Maverick Capital Ltd. now owns 2,553,237 shares of the company’s stock valued at $57,933,000 after buying an additional 306,314 shares in the last quarter. Bank of America Corp DE raised its holdings in shares of Acadia Healthcare by 60.2% during the 2nd quarter. Bank of America Corp DE now owns 1,156,484 shares of the company’s stock worth $26,241,000 after acquiring an additional 434,382 shares in the last quarter. Finally, Amundi grew its holdings in shares of Acadia Healthcare by 1,006,804.5% in the second quarter. Amundi now owns 896,145 shares of the company’s stock valued at $20,782,000 after purchasing an additional 896,056 shares in the last quarter.

Analysts Set New Price Targets

Several brokerages have commented on ACHC. Mizuho cut their price objective on Acadia Healthcare from $22.00 to $17.00 and set a “neutral” rating on the stock in a research report on Thursday, December 18th. Deutsche Bank Aktiengesellschaft cut their target price on shares of Acadia Healthcare from $33.00 to $20.00 and set a “buy” rating on the stock in a research report on Wednesday, December 3rd. Royal Bank Of Canada boosted their price objective on shares of Acadia Healthcare from $17.00 to $28.00 and gave the stock an “outperform” rating in a research note on Thursday. Raymond James Financial reiterated an “outperform” rating and issued a $25.00 price target on shares of Acadia Healthcare in a report on Thursday. Finally, Guggenheim reduced their target price on shares of Acadia Healthcare from $27.00 to $22.00 and set a “buy” rating for the company in a report on Monday, February 23rd. Seven analysts have rated the stock with a Buy rating, six have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $20.69.

Acadia Healthcare News Summary

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Q4 revenue topped estimates and EPS beat consensus, driving a strong intraday jump; management provided FY2026 and Q1 2026 guidance that gave investors a clearer outlook. Acadia Healthcare’s (NASDAQ:ACHC) Q4 CY2025 Sales Top Estimates, Stock Jumps 10.8%
• Positive Sentiment: The company posted its Q4 earnings presentation and materials, helping investors parse revenue mix, margin drivers and the path to management’s FY26 targets. Acadia Healthcare Company, Inc. 2025 Q4 – Results – Earnings Call Presentation
• Positive Sentiment: Multiple brokerages raised price targets and maintain buy/outperform stances—RBC to $28 (outperform), UBS to $27 (buy) and TD Cowen to $24 (buy)—which increases buy-side conviction and likely supported the rally. Benzinga: Analyst Price-Target Updates
• Positive Sentiment: Analysts and commentary highlighted improving execution and embedded EBITDA opportunities under returning management, reinforcing the view that operational fixes could restore profitability. TipRanks: Buy Rating on Improving Execution
• Neutral Sentiment: Aggregated analyst coverage: a Benzinga deep-dive summarizes 17 analyst ratings and consensus perspectives — useful for context on how Street expectations are shifting but not a single catalyst. Acadia Healthcare Co Stock: A Deep Dive Into Analyst Perspectives (17 Ratings)
• Negative Sentiment: Short interest remains very large (~32.45M shares as of mid‑Feb, ~35.9% of float) with a ~7.3 days-to-cover ratio — this high short position increases the risk of volatile trading, squeezes, or pressure if execution disappoints. (short-interest reports summarized in filings and market data)

Acadia Healthcare Stock Performance

NASDAQ ACHC opened at $23.44 on Monday. Acadia Healthcare Company, Inc. has a fifty-two week low of $11.43 and a fifty-two week high of $33.58. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.44 and a current ratio of 1.55. The firm has a market capitalization of $2.16 billion, a P/E ratio of -1.92, a PEG ratio of 8.01 and a beta of 0.89. The stock has a 50-day simple moving average of $14.82 and a two-hundred day simple moving average of $18.55.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, February 25th. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.04. The firm had revenue of $821.46 million during the quarter, compared to analyst estimates of $800.10 million. Acadia Healthcare had a negative net margin of 33.29% and a positive return on equity of 6.53%. The business’s quarterly revenue was up 6.1% on a year-over-year basis. During the same period in the previous year, the firm earned $0.64 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. On average, equities analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.